Register Cart 0

Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back Subscribe

Editorial

Editorial: The microRNA 221/222 Cluster: Inaugurating a New Era in Cardiovascular Disease and Cancer?

Author(s): Konstantinos Imprialos, Doumas M., Maria Tokamani, Raphael Sandaltzopoulos and Vasilios G. Athyros

Volume 15, Issue 1, 2017

Page: [47 - 50] Pages: 4

DOI: 10.2174/1381612822999161003224442

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

43

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Role of Resistin in Insulin Sensitivity in Rodents and Humans
Current Protein & Peptide Science

Matrix Metalloproteinases: Drug Targets for Myocardial Infarction
Current Drug Targets

Strict Adherence to Guidelines in Decision Making for Coronary Angiography in Patients Who have Survived a Q Wave Myocardial Infarction; 2-Year Outcome in a Greek Population
Vascular Disease Prevention (Discontinued)

Radiologic Findings of IgG4-Related Disease
Current Immunology Reviews (Discontinued)

Cardiovascular Disease in the Systemic Vasculitides
Current Vascular Pharmacology

Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies
Current Drug Targets

Oxidative Stress and Endothelial Dysfunction: Say NO to Cigarette Smoking!
Current Pharmaceutical Design

Anesthetic Considerations for Electroconvulsive Therapy-Especially Hemodynamic and Respiratory Management
Current Psychiatry Reviews

The Role of Endothelial Dysfunction in Aortic Aneurysms
Current Pharmaceutical Design

Biodegradable Composite Scaffolds: A Strategy to Modulate Stem Cell Behaviour
Recent Patents on Drug Delivery & Formulation

Clinical Applications of Cardiovascular Magnetic Resonance
Current Pharmaceutical Design

CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design

Platelets in Rheumatic Diseases: Friend or Foe?
Current Pharmaceutical Design

Platelet Activating Factor/Platelet Activating Factor Receptor Pathway as a Potential Therapeutic Target in Autoimmune Diseases
Inflammation & Allergy - Drug Targets (Discontinued)

Indications for Surgery and Operative Techniques in Infective Endocarditis in the Present Day
Infectious Disorders - Drug Targets

Editorial (Thematic Issue: Combination Therapy of Vascular Diseases and Fangjiomics: When West Meets East in the Era of Phenomics)
Current Vascular Pharmacology

Cardiac Tissue Engineering
Recent Patents on Regenerative Medicine

Urokinase-a Very Popular Cardiovascular Agent
Recent Patents on Cardiovascular Drug Discovery

Patent Selections
Recent Patents on Cardiovascular Drug Discovery

Novel Aspects in the Pathophysiology of Peripheral Vasculopathy in Systemic Sclerosis
Current Rheumatology Reviews

© 2025 Bentham Science Publishers | Privacy Policy